Objective: To clarify the association between atherosclerotic cerebral infarction (ACI) and the single nucleotide polymorphisms (SNP) rs1234313 and rs1234314 (in TNFSF4) and rs17568 (in TNFRSF4). Methods: Genomic DNA was extracted from peripheral blood of patients with ACI and healthy control subjects. The presence of carotid plaque was determined. Rs1234313, rs1234314 and rs17568 were characterized via SNP genotyping assay and verified by DNA sequencing. Results: Genotype distributions were in Hardy-Weinberg equilibrium. There were no significant differences in the allele and genotype distributions of rs1234313, rs1234314 and rs17568 between patients with ACI (n ¼ 450) and healthy control subjects (n ¼ 378), or between patients with ACI and carotid plaque (n ¼ 342) and controls. Conclusions: There were no significant associations between rs1234313, rs1234314 and rs17568 and ACI risk in a Han Chinese population.
Introduction
The TNFSF4 gene (tumour necrosis factor ligand superfamily member 4; also known as OX40L) is expressed by activated B cells, endothelial cells, and activated CD4 þ and CD8 þ T-cells. [1] [2] [3] The TNFSF4 receptor, TNFRSF4 (tumour necrosis factor receptor superfamily member 4; also known as OX40) is also expressed on activated T cells. 4 TNFSF4 is a T-cell activator that promotes the survival of CD4 þ T-cells at sites of inflammation 5 and plays a role in diseases with an inflammatory component. 6 When activated, T cells produce proinflammatory cytokines, which are largely responsible for plaque rupture and thrombus formation. 7 Evidence suggests that TNFSF4 and TNFRSF4 influence susceptibility to atherosclerosis and atherosclerotic disease. 6, [8] [9] [10] [11] [12] [13] Single nucleotide polymorphisms (SNP) in TNFSF4 are associated with myocardial infarction 8, 10 and venous thromboembolism. 14 In addition, there is evidence that TNFSF4 mRNA levels are significantly higher in human carotid atherosclerotic lesions, but the TNFSF4 SNP rs3850641 is not associated with ischaemic stroke risk. 9 We have shown that the TNFSF4 SNP rs3861950 is associated with the risk of atherosclerotic cerebral infarction (ACI), but that rs3850641 is not associated with ACI risk. 15 In contrast, others have found no significant association between TNFSF4 SNP (including rs3850641, rs3861950 and rs1234313) and the severity of coronary heart disease, 16 myocardial infarction, 17 and carotid atherosclerotic plaque thickening. 18 A study in a Chinese population found that the TNFRSF4 SNP rs17568 is associated with coronary syndrome risk, whereas the TNFSF4 SNP rs3850641 is not. 8 TNFRSF4 has also been shown to be a susceptibility gene in essential hypertension. 19 Little is known about the role of TNFSF4 and TNFRSF4 in ACI, however.
Worldwide, ACI is the most common form of stroke, and stroke is the leading cause of death in China. 20 The inflammatory response plays a decisive role at different stages of atherosclerosis and throughout the progression of ACI. 21 Carotid plaque, which is a distinct phenotype of subclinical atherosclerosis, is an inflammatory lesion associated with a significantly increased risk of ACI. 22, 23 The aim of the present study was to clarify the potential association between ACI and the SNP rs1234313 and rs1234314 (both located in the TNFSF4 promoter region) and the TNFRSF4 SNP rs17568, via SNP genotyping assay and genomic DNA sequencing, in patients with ACI and age-matched healthy control subjects.
Patients and methods

Study population
The study recruited ethnically Han Chinese patients with ACI, diagnosed according to the classification of acute stroke. 15 The presence of carotid atherosclerotic plaque was defined as an area of focal wall thickening more than 50% greater than surrounding wall thickness. 18, 22 The control population included age-and sex-matched unrelated subjects undergoing routine health screening at Xiangya Hospital during the same period. Exclusion criteria were: carotid plaque disclosed by ultrasonography; atherosclerotic retinopathy disclosed by ophthalmoscopy; history of cerebrovascular or cardiovascular disease; family history of stroke; cardiac arrhythmia; haematological disease; endocrine or metabolic disorders; pregnancy.
For all participants, total serum cholesterol, triglyceride, low-density lipoprotein cholesterol (LDL-C) and high-density lipoprotein cholesterol (HDL-C) were quantified according to standard procedures.
The study was approved by the Ethics Committee of Central South University and written informed consent was obtained from all participants.
Genetic analyses
Peripheral blood (5 ml) was collected in sterile tubes containing disodium ethylenediaminetetra-acetic acid and stored at À20 C until analysis. Genomic DNA was extracted using a DNA blood kit (Qiagen, Venlo, Netherlands) according to the manufacturer's instructions.
Allele-specific TaqMan Õ (Life Technologies, Carlsbad, CA, USA) probes and primers were used for the allelic discrimination of specific SNP. Primer and probe sequences are shown in Tables 1 and 2 (Shanghai Gene Core Bio Technologies Company, Shanghai, China). TaqMan Õ polymerase chain reaction (PCR) Table 1 . Polymerase chain reaction primer and allele-specific probe sequences for characterization of the single nucleotide polymorphisms (SNP) rs1234313, rs1234314 and rs17568.
SNP
Primer/probe Sequence rs1234313 Forward primer Table 3 . There were no statistically significant between-group differences in age,sex distribution, body mass index (BMI) or LDL-C. Tobacco use, alcohol consumption, blood sugar and triglycerides were significantly higher and total cholesterol and HDL-C were significantly lower in patients with ACI compared with controls (P < 0.05 for each comparison; Table 3 ). Carotid atherosclerotic plaque was present in 342/450 (76.0%) of the patients with ACI. The distributions of rs1234313, rs123414 and rs17568 were in Hardy-Weinberg equilibrium in both the patient and control groups. DNA sequencing indicated that the TaqMan Õ PCR technique was highly reproducible, with good sensitivity and specificity (data not shown).
Genotypic and allelic frequency distributions of the three SNP are shown in Table 4 . There were no statistically significant differences in genotype or allele frequency between control subjects and patients with ACI (with or without carotid plaque). In addition, there were no significant betweensex differences in genotype or allele frequency (data not shown).
Discussion
Data from the present study indicate that there were no significant differences between patients with ACI and healthy control subjects in genome or allele frequency of TNFSF4 rs1234313 and rs1234314, and TNFRSF4 rs17568. In addition, there were no significant differences between controls and patients with both ACI and carotid plaque. This finding suggests that these gene polymorphisms are not associated with ACI in the Han Chinese population.
The TNFSF4/TNFRSF4 pathway plays a key role in atherosclerosis and atherosclerotic disease. [8] [9] [10] [11] [12] [13] 27, 28 Targeted TNFSF4 mutation attenuates the atherosclerotic process in mice, while TNFSF4 overexpression exacerbates atherosclerosis. 8 It is unclear which TNFSF4/TNFRSF4 polymorphisms are associated with atherosclerotic disease, however. 8, 12, 17, 18 We have shown that the TNFSF4 SNP rs3861950 (but not rs3850641) was associated ACI risk in a Han Chinese population. 15 The present finding that TNFSF4 rs1234313 and rs1234314 were not associated with ACI is consistent with findings from Chinese 16 Swedish, 9 and German populations 17 that found no relationship between these two SNP and myocardial infarction.
There is evidence that TNFRSF4 colocalizes with an atherosclerosis quantitative trait locus in mice 29 and with a myocardial infarction locus in humans. 30 There was no significant difference in genome or allele frequency of TNFRSF4 SNP rs17568 between patients with ACI and control subjects in the present study. This finding is in accordance with a study from Sweden, in which the less-common allele of rs17568 did not affect the protein product and was not associated with myocardial infarction. 11 In contrast with the present data, a study of a Chinese population found that carriers of the rs17568 G allele had a significantly increased risk of acute coronary syndrome. 12 Carotid plaque is a distinct phenotype of subclinical atherosclerosis that is strongly associated with increased risk of ACI, 22, 23 but the role of TNFSF4/TNFRSF4 in carotid plaque-associated ACI is unclear. TNFSF4 mRNA levels were found to be significantly higher in human carotid atherosclerotic lesions than normal tissue, but TNFSF4 rs3850641 was not associated with ischaemic stroke risk. 9 Although rs1234313 may be associated with carotid plaque thickening, 18 there was no relationship between rs1234313 and ACI risk in the present study. The interaction between genetic and environmental factors may explain the variation in prevalence of atherosclerotic diseases in different populations. Indeed, we have previously provided evidence for an association between TNFSF4 rs3861950 and ACI risk in a Han Chinese population. 15 ACI has a complex aetiology involving multiple genes and nongenetic factors. 18, 20 Given the role of TNFSF4/TNFRSF4 as regulators of immune and inflammatory processes involved in atherosclerotic disease, further studies involving larger populations are warranted, to clarify the impact of polymorphisms on the risk of ACI.
In conclusion, the present study found no significant association between ACI risk in a Han Chinese population and the TNFSF4/ TNFRSF4 SNP rs1234313, rs1234314 and rs17568. Data presented as n (%). OR, odds ratio; 95% CI, 95% confidence interval. No statistically significant between-group differences (P ! 0.05; 2 -test).
